Elevate your local knowledge
Sign up for the iNFOnews newsletter today!
Study: Cheap chemo drug greatly boosts survival for men with advanced prostate cancer
[byline]
Original Publication Date: June 1, 2014 1:30AM
Publication Updated: January 8, 2025 11:03PM
CHICAGO – A study shows that a cheap, decades-old chemotherapy drug extended life by more than a year when added to standard hormone therapy for men with prostate cancer that has spread.
It’s one of the biggest improvements in survival ever seen in an advanced cancer in adults.
Men who received the drug docetaxel (doe-suh-TAX-uhl) lived nearly 58 months versus 44 months for those not given the drug in the study, which was sponsored by the federal government.
The results were discussed Sunday at a meeting of more than 30,000 cancer specialists in Chicago.
Doctors say it shows the importance of testing older medicines now available in generic form. This one costs about $1,500 per treatment, far less than many newer drugs.
News from © The Associated Press, . All rights reserved.
This material may not be published, broadcast, rewritten or redistributed.
Join the Conversation!
Want to share your thoughts, add context, or connect with others in your community?
You must be logged in to post a comment.
